CDXI

Cardax, Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 4/28/2017
Contact Info
  • 2800 Woodlawn Drive
  • Suite 129
  • Honolulu, HI 96822

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001544238
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2006
Employees 8 a/o Nov 14, 2016
Company Officers/Contacts
David G. Watumull CEO, President
David M. Watumull COO, Asst. Treasurer, Asst. Secretary
John B. Russell CFO, Treasurer
Richard M. Morris Secretary
Company Directors
George W. Bickerstaff, III Chairman
Michele Galen
Terence A. Kelly, Ph.D.
David G. Watumull
Company Notes
  • Formerly=Koffee Korner Inc until 2-2014
Service Providers
Accounting/Auditing Firm
KBL, LLP
114 West 47th Street, 19th Floor
Suite 1900
New York, NY, 10036
United States

Legal Counsel
Herrick Feinstein LLP
Two Park Ave
New York, NY, 10016
United States

Investor Relations Firm
Not Available
CDXI Security Details
Share Structure
Market Value1 $53,471,504 a/o Sep 21, 2017
Authorized Shares 400,000,000 a/o Sep 01, 2017
Outstanding Shares 106,985,803 a/o Sep 01, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 3,345,914 a/o Mar 12, 2015
Par Value 0.0001
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders
Shareholders of Record 450 a/o Nov 11, 2016
Short Selling Data
Short Interest 32,296 (108.36%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security